Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shaughnessy

Showing results (61-70 of 194) with videos related to

Pageof 20
Sort By:
Oncogene|May 18, 2000
Evi27 encodes a novel membrane protein with homology to the IL17 receptorE Tian, J R Sawyer, D A Largaespada, et al.
American Journal of Clinical Pathology|December 20, 2011
Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myelomaDaisy Alapat, Jean Coviello-Malle, Rebecca Owens, et al.
Plos One|December 29, 2010
Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous boneAngela Pennisi, Wen Ling, Xin Li, et al.
Clinical Hematology International|February 3, 2023
Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple MyelomaSamer Al Hadidi, Deepa Dongarwar, Carolina Schinke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment armsBart Barlogie, Elias Anaissie, Frits van Rhee, et al.
BMC Medical Genomics|June 3, 2014
Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical useRyan van Laar, Rachel Flinchum, Nathan Brown, et al.
International Journal of Hematology|October 18, 2011
The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myelomaSarah K Johnson, Christoph J Heuck, Anthony P Albino, et al.
Oncogene|November 1, 1993
Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extentsJ D Shaughnessy, J D Owens, F Wiener, et al.
Blood|February 29, 2008
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myelomaYa-Wei Qiang, Yu Chen, Owen Stephens, et al.
Genomics|April 1, 1996
Mouse chromosomal location of three epithelial sodium channel subunit genes and an apical sodium chloride cotransporter geneB G Pathak, J D Shaughnessy, P Meneton, et al.
Pageof 20

Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
Oncogene|May 18, 2000
Evi27 encodes a novel membrane protein with homology to the IL17 receptorE Tian, J R Sawyer, D A Largaespada, et al.
American Journal of Clinical Pathology|December 20, 2011
Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myelomaDaisy Alapat, Jean Coviello-Malle, Rebecca Owens, et al.
Plos One|December 29, 2010
Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous boneAngela Pennisi, Wen Ling, Xin Li, et al.
Clinical Hematology International|February 3, 2023
Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple MyelomaSamer Al Hadidi, Deepa Dongarwar, Carolina Schinke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment armsBart Barlogie, Elias Anaissie, Frits van Rhee, et al.
BMC Medical Genomics|June 3, 2014
Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical useRyan van Laar, Rachel Flinchum, Nathan Brown, et al.
International Journal of Hematology|October 18, 2011
The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myelomaSarah K Johnson, Christoph J Heuck, Anthony P Albino, et al.
Oncogene|November 1, 1993
Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extentsJ D Shaughnessy, J D Owens, F Wiener, et al.
Blood|February 29, 2008
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myelomaYa-Wei Qiang, Yu Chen, Owen Stephens, et al.
Genomics|April 1, 1996
Mouse chromosomal location of three epithelial sodium channel subunit genes and an apical sodium chloride cotransporter geneB G Pathak, J D Shaughnessy, P Meneton, et al.
Pageof 20